PRTA FY 2020 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$853,000+4.8% YoY

Gross Profit

-$74M-8678.9% margin

Operating Income

-$113M-13216.2% margin

Net Income

-$111M-13029.8% margin

EPS (Diluted)

$-2.78

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$81M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$333M

Total Liabilities

$149M

Stockholders' Equity

$184M

Cash & Equivalents

$295M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$853,000	$814,000	+4.8%
Gross Profit	-$74M	-$50M	-48.0%
Operating Income	-$113M	-$86M	-31.5%
Net Income	-$111M	-$78M	-43.1%